[MACRO-EYES SIMILARITY ENGINE]
Providers will be able to see a single patient in high-level context and bring details into sharp focus: clinicians will magnify the trend line of a series of lab values and discover how a change of that kind typically progresses during the care of similar patients – and which interventions prompted a shift.
Clinicians will again be generalists. They will make decisions by pairing rapidly acquired data with dynamic models of medicine. Insight will move clinicians and administrators from the micro to the macro and allow visibility into the connections therebetween.
The health systems of the future will allow patients and providers to see the interventions that create value specifically for them. Supply chain executives will leverage insight on the devices and medications that lead to optimal outcomes for different cohorts of patients; supply chain will negotiate on price and specifications with device manufacturers and pharmaceutical companies to create value for the population in their care.
The medical solutions of the future will be personalized to the patient. Personalization will not be static or reducible to keywords. Personalization will be more than diabetic/female/adult. Personalization is not only genomics. The maxim that Google or Facebook knows more about you than your physician will no longer be true (if it ever was). In the future, Google will look to healthcare to learn effective ad-targeting. Technology companies will study how providers leverage data to effectively treat different types of patients; data generated by patients’ bodies and data recorded in the environments where they live and work.